DYNAVAX TECHNOLOGIES DVAX (NASDAQ) $ 0.22 Change: 0 0% | Volume: 323,165
Sponsored by Click here!

DYNAVAX TECH CP - Fundamental Profile

Company Information

Ticker Symbol: DVAX
Exchange: NASD
Contact Info: 2929 Seventh Street Berkeley CA 94710-2753 510 848-5100
CEO/President: Dino Dina M.D.
Industry: Medical - Biomedical / Standard Industry Code: 2834
Description: Dynavax Technologies discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Dynavax\'s clinical development programs are based on immunostimulatory sequences which are short DNA sequences that enhance the ability of the immune system to fight disease and control chronic inflammation.

Share Information

Shares Outstanding: 39,810 (000) Market Value: 10,350 ($000)
Percentage of Inst.Shareholders: 62.31% Number of Inst.Shareholders: 5.80%
Last Quarter Sales: 8.86 ($Mil.) Last Quarter Net Income: -5.42 ($Mil.)
Last Quarter EPS: -0.14 P/E Ratio: 0
Most Recent Earnings: Earnings Per Share: -0.90
Most Recent Split: Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

AMGEN +12.60 58.23
GILEAD SCIENCES -1.00 46.92
CELGENE CP -10.00 58.86
BIOGEN IDEC INC -31.90 43.52
AMYLIN PHARMA I -85.70 6.41